Cancer Cell International-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2197688, encodeId=3cb0219e688b1, content=这个杂志平均审稿时间感觉不是官网上说的那么快啊，我的1月底投，现在都还在外审，只有1个外审意见回来了，还在等另外一个外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5fc8852742, createdName=ms6000001772473137, createdTime=Wed Apr 10 01:37:05 CST 2024, time=2024-04-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2197377, encodeId=a25b219e37740, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：纯生信现在不要了得加实验主要审稿速度2023年后就出奇的慢，3个半月一审意见才回来而且只有一个审稿人的意见，修回后一直同行评审了20天了，啥动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67526580859, createdName=ms9000000438456105, createdTime=Mon Apr 08 12:01:16 CST 2024, time=2024-04-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185531, encodeId=713d218553185, content=editor appointed半个多月了，要催么，最近大家有投稿的么，什么时候能进入下一个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db952300595, createdName=12206c44m25(暂无昵称), createdTime=Fri Feb 02 17:24:29 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176856, encodeId=74c821e685641, content=偏重的研究方向：肿瘤;生信 经验分享：投稿第二天就editor appointed了，现在已经差不多两个月了，发了邮件催，回复说已经在找审稿人了。这个杂志是比较慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Dec 24 14:18:54 CST 2023, time=2023-12-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2190233, encodeId=e3cf21902338a, content=投稿通过初始审查后变为Peer review, "We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.",这是还没分配编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=020a5519115, createdName=火舞, createdTime=Thu Feb 29 23:01:19 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186670, encodeId=db5621866e06e, content=请问下大家，一审是大修，二审小修的话还会送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d2e5075184, createdName=1459fafam67暂无昵称, createdTime=Fri Feb 09 11:31:44 CST 2024, time=2024-02-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2162924, encodeId=d678216292445, content=我的天啊，这个杂志是没有人吗？怎么这么慢？已经半年了还在peer review，别再等几个月回来个拒绝，那我就可以泪洒长江了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88438132359, createdName=ms1000001361403109, createdTime=Sun Oct 15 20:23:22 CST 2023, time=2023-10-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1053746, encodeId=75fe1053e4663, content=审稿速度:2.0 经验分享：7.16投稿，9.20小修，要补动物实验，加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/f561376675e24537beed7d75b145e112/869c7ba506174d3d9b0c77a2ea6180b2.jpg, createdBy=4fe22307227, createdName=小啵啵嘟, createdTime=Wed Sep 22 11:57:09 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214367, encodeId=1099121436e25, content=偏重的研究方向：肿瘤;Cancer 经验分享：我的二审修回1个月了，都还是reviewers invited，有没有小伙伴能指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/acd275c8ee710a029c1f67cc80ff2472.jpg, createdBy=28492314309, createdName=章晓风, createdTime=Tue Apr 26 00:13:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198917, encodeId=5e2f119891e60, content=偏重的研究方向：肿瘤;细胞生物学 经验分享：2021-11-15投稿，2022-03-01接收，两个审稿人提出了十几条意见，认真回复了，让补实验没有补，后来修回以后审稿人没有意见了又找了第三个审稿人，让补实验没有补，小修回去接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu Mar 03 01:04:38 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2024-04-10 ms6000001772473137 来自上海

这个杂志平均审稿时间感觉不是官网上说的那么快啊，我的1月底投，现在都还在外审，只有1个外审意见回来了，还在等另外一个外审意见

3 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197688, encodeId=3cb0219e688b1, content=这个杂志平均审稿时间感觉不是官网上说的那么快啊，我的1月底投，现在都还在外审，只有1个外审意见回来了，还在等另外一个外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5fc8852742, createdName=ms6000001772473137, createdTime=Wed Apr 10 01:37:05 CST 2024, time=2024-04-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2197377, encodeId=a25b219e37740, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：纯生信现在不要了得加实验主要审稿速度2023年后就出奇的慢，3个半月一审意见才回来而且只有一个审稿人的意见，修回后一直同行评审了20天了，啥动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67526580859, createdName=ms9000000438456105, createdTime=Mon Apr 08 12:01:16 CST 2024, time=2024-04-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185531, encodeId=713d218553185, content=editor appointed半个多月了，要催么，最近大家有投稿的么，什么时候能进入下一个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db952300595, createdName=12206c44m25(暂无昵称), createdTime=Fri Feb 02 17:24:29 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176856, encodeId=74c821e685641, content=偏重的研究方向：肿瘤;生信 经验分享：投稿第二天就editor appointed了，现在已经差不多两个月了，发了邮件催，回复说已经在找审稿人了。这个杂志是比较慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Dec 24 14:18:54 CST 2023, time=2023-12-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2190233, encodeId=e3cf21902338a, content=投稿通过初始审查后变为Peer review, "We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.",这是还没分配编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=020a5519115, createdName=火舞, createdTime=Thu Feb 29 23:01:19 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186670, encodeId=db5621866e06e, content=请问下大家，一审是大修，二审小修的话还会送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d2e5075184, createdName=1459fafam67暂无昵称, createdTime=Fri Feb 09 11:31:44 CST 2024, time=2024-02-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2162924, encodeId=d678216292445, content=我的天啊，这个杂志是没有人吗？怎么这么慢？已经半年了还在peer review，别再等几个月回来个拒绝，那我就可以泪洒长江了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88438132359, createdName=ms1000001361403109, createdTime=Sun Oct 15 20:23:22 CST 2023, time=2023-10-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1053746, encodeId=75fe1053e4663, content=审稿速度:2.0 经验分享：7.16投稿，9.20小修，要补动物实验，加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/f561376675e24537beed7d75b145e112/869c7ba506174d3d9b0c77a2ea6180b2.jpg, createdBy=4fe22307227, createdName=小啵啵嘟, createdTime=Wed Sep 22 11:57:09 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214367, encodeId=1099121436e25, content=偏重的研究方向：肿瘤;Cancer 经验分享：我的二审修回1个月了，都还是reviewers invited，有没有小伙伴能指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/acd275c8ee710a029c1f67cc80ff2472.jpg, createdBy=28492314309, createdName=章晓风, createdTime=Tue Apr 26 00:13:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198917, encodeId=5e2f119891e60, content=偏重的研究方向：肿瘤;细胞生物学 经验分享：2021-11-15投稿，2022-03-01接收，两个审稿人提出了十几条意见，认真回复了，让补实验没有补，后来修回以后审稿人没有意见了又找了第三个审稿人，让补实验没有补，小修回去接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu Mar 03 01:04:38 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2024-04-08 ms9000000438456105 来自天津

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：纯生信现在不要了得加实验主要审稿速度2023年后就出奇的慢，3个半月一审意见才回来而且只有一个审稿人的意见，修回后一直同行评审了20天了，啥动静都没有。

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2197688, encodeId=3cb0219e688b1, content=这个杂志平均审稿时间感觉不是官网上说的那么快啊，我的1月底投，现在都还在外审，只有1个外审意见回来了，还在等另外一个外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5fc8852742, createdName=ms6000001772473137, createdTime=Wed Apr 10 01:37:05 CST 2024, time=2024-04-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2197377, encodeId=a25b219e37740, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：纯生信现在不要了得加实验主要审稿速度2023年后就出奇的慢，3个半月一审意见才回来而且只有一个审稿人的意见，修回后一直同行评审了20天了，啥动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67526580859, createdName=ms9000000438456105, createdTime=Mon Apr 08 12:01:16 CST 2024, time=2024-04-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185531, encodeId=713d218553185, content=editor appointed半个多月了，要催么，最近大家有投稿的么，什么时候能进入下一个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db952300595, createdName=12206c44m25(暂无昵称), createdTime=Fri Feb 02 17:24:29 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176856, encodeId=74c821e685641, content=偏重的研究方向：肿瘤;生信 经验分享：投稿第二天就editor appointed了，现在已经差不多两个月了，发了邮件催，回复说已经在找审稿人了。这个杂志是比较慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Dec 24 14:18:54 CST 2023, time=2023-12-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2190233, encodeId=e3cf21902338a, content=投稿通过初始审查后变为Peer review, "We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.",这是还没分配编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=020a5519115, createdName=火舞, createdTime=Thu Feb 29 23:01:19 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186670, encodeId=db5621866e06e, content=请问下大家，一审是大修，二审小修的话还会送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d2e5075184, createdName=1459fafam67暂无昵称, createdTime=Fri Feb 09 11:31:44 CST 2024, time=2024-02-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2162924, encodeId=d678216292445, content=我的天啊，这个杂志是没有人吗？怎么这么慢？已经半年了还在peer review，别再等几个月回来个拒绝，那我就可以泪洒长江了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88438132359, createdName=ms1000001361403109, createdTime=Sun Oct 15 20:23:22 CST 2023, time=2023-10-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1053746, encodeId=75fe1053e4663, content=审稿速度:2.0 经验分享：7.16投稿，9.20小修，要补动物实验，加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/f561376675e24537beed7d75b145e112/869c7ba506174d3d9b0c77a2ea6180b2.jpg, createdBy=4fe22307227, createdName=小啵啵嘟, createdTime=Wed Sep 22 11:57:09 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214367, encodeId=1099121436e25, content=偏重的研究方向：肿瘤;Cancer 经验分享：我的二审修回1个月了，都还是reviewers invited，有没有小伙伴能指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/acd275c8ee710a029c1f67cc80ff2472.jpg, createdBy=28492314309, createdName=章晓风, createdTime=Tue Apr 26 00:13:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198917, encodeId=5e2f119891e60, content=偏重的研究方向：肿瘤;细胞生物学 经验分享：2021-11-15投稿，2022-03-01接收，两个审稿人提出了十几条意见，认真回复了，让补实验没有补，后来修回以后审稿人没有意见了又找了第三个审稿人，让补实验没有补，小修回去接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu Mar 03 01:04:38 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2024-02-02 12206c44m25(暂无昵称) 来自上海

editor appointed半个多月了，要催么，最近大家有投稿的么，什么时候能进入下一个状态

25 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197688, encodeId=3cb0219e688b1, content=这个杂志平均审稿时间感觉不是官网上说的那么快啊，我的1月底投，现在都还在外审，只有1个外审意见回来了，还在等另外一个外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5fc8852742, createdName=ms6000001772473137, createdTime=Wed Apr 10 01:37:05 CST 2024, time=2024-04-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2197377, encodeId=a25b219e37740, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：纯生信现在不要了得加实验主要审稿速度2023年后就出奇的慢，3个半月一审意见才回来而且只有一个审稿人的意见，修回后一直同行评审了20天了，啥动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67526580859, createdName=ms9000000438456105, createdTime=Mon Apr 08 12:01:16 CST 2024, time=2024-04-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185531, encodeId=713d218553185, content=editor appointed半个多月了，要催么，最近大家有投稿的么，什么时候能进入下一个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db952300595, createdName=12206c44m25(暂无昵称), createdTime=Fri Feb 02 17:24:29 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176856, encodeId=74c821e685641, content=偏重的研究方向：肿瘤;生信 经验分享：投稿第二天就editor appointed了，现在已经差不多两个月了，发了邮件催，回复说已经在找审稿人了。这个杂志是比较慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Dec 24 14:18:54 CST 2023, time=2023-12-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2190233, encodeId=e3cf21902338a, content=投稿通过初始审查后变为Peer review, "We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.",这是还没分配编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=020a5519115, createdName=火舞, createdTime=Thu Feb 29 23:01:19 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186670, encodeId=db5621866e06e, content=请问下大家，一审是大修，二审小修的话还会送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d2e5075184, createdName=1459fafam67暂无昵称, createdTime=Fri Feb 09 11:31:44 CST 2024, time=2024-02-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2162924, encodeId=d678216292445, content=我的天啊，这个杂志是没有人吗？怎么这么慢？已经半年了还在peer review，别再等几个月回来个拒绝，那我就可以泪洒长江了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88438132359, createdName=ms1000001361403109, createdTime=Sun Oct 15 20:23:22 CST 2023, time=2023-10-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1053746, encodeId=75fe1053e4663, content=审稿速度:2.0 经验分享：7.16投稿，9.20小修，要补动物实验，加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/f561376675e24537beed7d75b145e112/869c7ba506174d3d9b0c77a2ea6180b2.jpg, createdBy=4fe22307227, createdName=小啵啵嘟, createdTime=Wed Sep 22 11:57:09 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214367, encodeId=1099121436e25, content=偏重的研究方向：肿瘤;Cancer 经验分享：我的二审修回1个月了，都还是reviewers invited，有没有小伙伴能指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/acd275c8ee710a029c1f67cc80ff2472.jpg, createdBy=28492314309, createdName=章晓风, createdTime=Tue Apr 26 00:13:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198917, encodeId=5e2f119891e60, content=偏重的研究方向：肿瘤;细胞生物学 经验分享：2021-11-15投稿，2022-03-01接收，两个审稿人提出了十几条意见，认真回复了，让补实验没有补，后来修回以后审稿人没有意见了又找了第三个审稿人，让补实验没有补，小修回去接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu Mar 03 01:04:38 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2023-12-24 ms3000001126828781 来自广西

偏重的研究方向：肿瘤;生信
经验分享：投稿第二天就editor appointed了，现在已经差不多两个月了，发了邮件催，回复说已经在找审稿人了。这个杂志是比较慢吗？

29 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197688, encodeId=3cb0219e688b1, content=这个杂志平均审稿时间感觉不是官网上说的那么快啊，我的1月底投，现在都还在外审，只有1个外审意见回来了，还在等另外一个外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5fc8852742, createdName=ms6000001772473137, createdTime=Wed Apr 10 01:37:05 CST 2024, time=2024-04-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2197377, encodeId=a25b219e37740, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：纯生信现在不要了得加实验主要审稿速度2023年后就出奇的慢，3个半月一审意见才回来而且只有一个审稿人的意见，修回后一直同行评审了20天了，啥动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67526580859, createdName=ms9000000438456105, createdTime=Mon Apr 08 12:01:16 CST 2024, time=2024-04-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185531, encodeId=713d218553185, content=editor appointed半个多月了，要催么，最近大家有投稿的么，什么时候能进入下一个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db952300595, createdName=12206c44m25(暂无昵称), createdTime=Fri Feb 02 17:24:29 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176856, encodeId=74c821e685641, content=偏重的研究方向：肿瘤;生信 经验分享：投稿第二天就editor appointed了，现在已经差不多两个月了，发了邮件催，回复说已经在找审稿人了。这个杂志是比较慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Dec 24 14:18:54 CST 2023, time=2023-12-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2190233, encodeId=e3cf21902338a, content=投稿通过初始审查后变为Peer review, "We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.",这是还没分配编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=020a5519115, createdName=火舞, createdTime=Thu Feb 29 23:01:19 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186670, encodeId=db5621866e06e, content=请问下大家，一审是大修，二审小修的话还会送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d2e5075184, createdName=1459fafam67暂无昵称, createdTime=Fri Feb 09 11:31:44 CST 2024, time=2024-02-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2162924, encodeId=d678216292445, content=我的天啊，这个杂志是没有人吗？怎么这么慢？已经半年了还在peer review，别再等几个月回来个拒绝，那我就可以泪洒长江了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88438132359, createdName=ms1000001361403109, createdTime=Sun Oct 15 20:23:22 CST 2023, time=2023-10-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1053746, encodeId=75fe1053e4663, content=审稿速度:2.0 经验分享：7.16投稿，9.20小修，要补动物实验，加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/f561376675e24537beed7d75b145e112/869c7ba506174d3d9b0c77a2ea6180b2.jpg, createdBy=4fe22307227, createdName=小啵啵嘟, createdTime=Wed Sep 22 11:57:09 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214367, encodeId=1099121436e25, content=偏重的研究方向：肿瘤;Cancer 经验分享：我的二审修回1个月了，都还是reviewers invited，有没有小伙伴能指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/acd275c8ee710a029c1f67cc80ff2472.jpg, createdBy=28492314309, createdName=章晓风, createdTime=Tue Apr 26 00:13:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198917, encodeId=5e2f119891e60, content=偏重的研究方向：肿瘤;细胞生物学 经验分享：2021-11-15投稿，2022-03-01接收，两个审稿人提出了十几条意见，认真回复了，让补实验没有补，后来修回以后审稿人没有意见了又找了第三个审稿人，让补实验没有补，小修回去接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu Mar 03 01:04:38 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2024-02-29 火舞来自湖北省

投稿通过初始审查后变为Peer review, "We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.",这是还没分配编辑吗？

14 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197688, encodeId=3cb0219e688b1, content=这个杂志平均审稿时间感觉不是官网上说的那么快啊，我的1月底投，现在都还在外审，只有1个外审意见回来了，还在等另外一个外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5fc8852742, createdName=ms6000001772473137, createdTime=Wed Apr 10 01:37:05 CST 2024, time=2024-04-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2197377, encodeId=a25b219e37740, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：纯生信现在不要了得加实验主要审稿速度2023年后就出奇的慢，3个半月一审意见才回来而且只有一个审稿人的意见，修回后一直同行评审了20天了，啥动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67526580859, createdName=ms9000000438456105, createdTime=Mon Apr 08 12:01:16 CST 2024, time=2024-04-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185531, encodeId=713d218553185, content=editor appointed半个多月了，要催么，最近大家有投稿的么，什么时候能进入下一个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db952300595, createdName=12206c44m25(暂无昵称), createdTime=Fri Feb 02 17:24:29 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176856, encodeId=74c821e685641, content=偏重的研究方向：肿瘤;生信 经验分享：投稿第二天就editor appointed了，现在已经差不多两个月了，发了邮件催，回复说已经在找审稿人了。这个杂志是比较慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Dec 24 14:18:54 CST 2023, time=2023-12-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2190233, encodeId=e3cf21902338a, content=投稿通过初始审查后变为Peer review, "We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.",这是还没分配编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=020a5519115, createdName=火舞, createdTime=Thu Feb 29 23:01:19 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186670, encodeId=db5621866e06e, content=请问下大家，一审是大修，二审小修的话还会送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d2e5075184, createdName=1459fafam67暂无昵称, createdTime=Fri Feb 09 11:31:44 CST 2024, time=2024-02-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2162924, encodeId=d678216292445, content=我的天啊，这个杂志是没有人吗？怎么这么慢？已经半年了还在peer review，别再等几个月回来个拒绝，那我就可以泪洒长江了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88438132359, createdName=ms1000001361403109, createdTime=Sun Oct 15 20:23:22 CST 2023, time=2023-10-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1053746, encodeId=75fe1053e4663, content=审稿速度:2.0 经验分享：7.16投稿，9.20小修，要补动物实验，加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/f561376675e24537beed7d75b145e112/869c7ba506174d3d9b0c77a2ea6180b2.jpg, createdBy=4fe22307227, createdName=小啵啵嘟, createdTime=Wed Sep 22 11:57:09 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214367, encodeId=1099121436e25, content=偏重的研究方向：肿瘤;Cancer 经验分享：我的二审修回1个月了，都还是reviewers invited，有没有小伙伴能指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/acd275c8ee710a029c1f67cc80ff2472.jpg, createdBy=28492314309, createdName=章晓风, createdTime=Tue Apr 26 00:13:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198917, encodeId=5e2f119891e60, content=偏重的研究方向：肿瘤;细胞生物学 经验分享：2021-11-15投稿，2022-03-01接收，两个审稿人提出了十几条意见，认真回复了，让补实验没有补，后来修回以后审稿人没有意见了又找了第三个审稿人，让补实验没有补，小修回去接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu Mar 03 01:04:38 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2024-02-09 1459fafam67暂无昵称来自湖南省

请问下大家，一审是大修，二审小修的话还会送外审吗？

22 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197688, encodeId=3cb0219e688b1, content=这个杂志平均审稿时间感觉不是官网上说的那么快啊，我的1月底投，现在都还在外审，只有1个外审意见回来了，还在等另外一个外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5fc8852742, createdName=ms6000001772473137, createdTime=Wed Apr 10 01:37:05 CST 2024, time=2024-04-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2197377, encodeId=a25b219e37740, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：纯生信现在不要了得加实验主要审稿速度2023年后就出奇的慢，3个半月一审意见才回来而且只有一个审稿人的意见，修回后一直同行评审了20天了，啥动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67526580859, createdName=ms9000000438456105, createdTime=Mon Apr 08 12:01:16 CST 2024, time=2024-04-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185531, encodeId=713d218553185, content=editor appointed半个多月了，要催么，最近大家有投稿的么，什么时候能进入下一个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db952300595, createdName=12206c44m25(暂无昵称), createdTime=Fri Feb 02 17:24:29 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176856, encodeId=74c821e685641, content=偏重的研究方向：肿瘤;生信 经验分享：投稿第二天就editor appointed了，现在已经差不多两个月了，发了邮件催，回复说已经在找审稿人了。这个杂志是比较慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Dec 24 14:18:54 CST 2023, time=2023-12-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2190233, encodeId=e3cf21902338a, content=投稿通过初始审查后变为Peer review, "We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.",这是还没分配编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=020a5519115, createdName=火舞, createdTime=Thu Feb 29 23:01:19 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186670, encodeId=db5621866e06e, content=请问下大家，一审是大修，二审小修的话还会送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d2e5075184, createdName=1459fafam67暂无昵称, createdTime=Fri Feb 09 11:31:44 CST 2024, time=2024-02-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2162924, encodeId=d678216292445, content=我的天啊，这个杂志是没有人吗？怎么这么慢？已经半年了还在peer review，别再等几个月回来个拒绝，那我就可以泪洒长江了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88438132359, createdName=ms1000001361403109, createdTime=Sun Oct 15 20:23:22 CST 2023, time=2023-10-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1053746, encodeId=75fe1053e4663, content=审稿速度:2.0 经验分享：7.16投稿，9.20小修，要补动物实验，加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/f561376675e24537beed7d75b145e112/869c7ba506174d3d9b0c77a2ea6180b2.jpg, createdBy=4fe22307227, createdName=小啵啵嘟, createdTime=Wed Sep 22 11:57:09 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214367, encodeId=1099121436e25, content=偏重的研究方向：肿瘤;Cancer 经验分享：我的二审修回1个月了，都还是reviewers invited，有没有小伙伴能指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/acd275c8ee710a029c1f67cc80ff2472.jpg, createdBy=28492314309, createdName=章晓风, createdTime=Tue Apr 26 00:13:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198917, encodeId=5e2f119891e60, content=偏重的研究方向：肿瘤;细胞生物学 经验分享：2021-11-15投稿，2022-03-01接收，两个审稿人提出了十几条意见，认真回复了，让补实验没有补，后来修回以后审稿人没有意见了又找了第三个审稿人，让补实验没有补，小修回去接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu Mar 03 01:04:38 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2023-10-15 ms1000001361403109 来自吉林省

我的天啊，这个杂志是没有人吗？怎么这么慢？已经半年了还在peer review，别再等几个月回来个拒绝，那我就可以泪洒长江了

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197688, encodeId=3cb0219e688b1, content=这个杂志平均审稿时间感觉不是官网上说的那么快啊，我的1月底投，现在都还在外审，只有1个外审意见回来了，还在等另外一个外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5fc8852742, createdName=ms6000001772473137, createdTime=Wed Apr 10 01:37:05 CST 2024, time=2024-04-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2197377, encodeId=a25b219e37740, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：纯生信现在不要了得加实验主要审稿速度2023年后就出奇的慢，3个半月一审意见才回来而且只有一个审稿人的意见，修回后一直同行评审了20天了，啥动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67526580859, createdName=ms9000000438456105, createdTime=Mon Apr 08 12:01:16 CST 2024, time=2024-04-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185531, encodeId=713d218553185, content=editor appointed半个多月了，要催么，最近大家有投稿的么，什么时候能进入下一个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db952300595, createdName=12206c44m25(暂无昵称), createdTime=Fri Feb 02 17:24:29 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176856, encodeId=74c821e685641, content=偏重的研究方向：肿瘤;生信 经验分享：投稿第二天就editor appointed了，现在已经差不多两个月了，发了邮件催，回复说已经在找审稿人了。这个杂志是比较慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Dec 24 14:18:54 CST 2023, time=2023-12-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2190233, encodeId=e3cf21902338a, content=投稿通过初始审查后变为Peer review, "We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.",这是还没分配编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=020a5519115, createdName=火舞, createdTime=Thu Feb 29 23:01:19 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186670, encodeId=db5621866e06e, content=请问下大家，一审是大修，二审小修的话还会送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d2e5075184, createdName=1459fafam67暂无昵称, createdTime=Fri Feb 09 11:31:44 CST 2024, time=2024-02-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2162924, encodeId=d678216292445, content=我的天啊，这个杂志是没有人吗？怎么这么慢？已经半年了还在peer review，别再等几个月回来个拒绝，那我就可以泪洒长江了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88438132359, createdName=ms1000001361403109, createdTime=Sun Oct 15 20:23:22 CST 2023, time=2023-10-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1053746, encodeId=75fe1053e4663, content=审稿速度:2.0 经验分享：7.16投稿，9.20小修，要补动物实验，加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/f561376675e24537beed7d75b145e112/869c7ba506174d3d9b0c77a2ea6180b2.jpg, createdBy=4fe22307227, createdName=小啵啵嘟, createdTime=Wed Sep 22 11:57:09 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214367, encodeId=1099121436e25, content=偏重的研究方向：肿瘤;Cancer 经验分享：我的二审修回1个月了，都还是reviewers invited，有没有小伙伴能指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/acd275c8ee710a029c1f67cc80ff2472.jpg, createdBy=28492314309, createdName=章晓风, createdTime=Tue Apr 26 00:13:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198917, encodeId=5e2f119891e60, content=偏重的研究方向：肿瘤;细胞生物学 经验分享：2021-11-15投稿，2022-03-01接收，两个审稿人提出了十几条意见，认真回复了，让补实验没有补，后来修回以后审稿人没有意见了又找了第三个审稿人，让补实验没有补，小修回去接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu Mar 03 01:04:38 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2021-09-22 小啵啵嘟

审稿速度:2.0
经验分享：7.16投稿，9.20小修，要补动物实验，加油吧

60 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197688, encodeId=3cb0219e688b1, content=这个杂志平均审稿时间感觉不是官网上说的那么快啊，我的1月底投，现在都还在外审，只有1个外审意见回来了，还在等另外一个外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5fc8852742, createdName=ms6000001772473137, createdTime=Wed Apr 10 01:37:05 CST 2024, time=2024-04-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2197377, encodeId=a25b219e37740, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：纯生信现在不要了得加实验主要审稿速度2023年后就出奇的慢，3个半月一审意见才回来而且只有一个审稿人的意见，修回后一直同行评审了20天了，啥动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67526580859, createdName=ms9000000438456105, createdTime=Mon Apr 08 12:01:16 CST 2024, time=2024-04-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185531, encodeId=713d218553185, content=editor appointed半个多月了，要催么，最近大家有投稿的么，什么时候能进入下一个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db952300595, createdName=12206c44m25(暂无昵称), createdTime=Fri Feb 02 17:24:29 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176856, encodeId=74c821e685641, content=偏重的研究方向：肿瘤;生信 经验分享：投稿第二天就editor appointed了，现在已经差不多两个月了，发了邮件催，回复说已经在找审稿人了。这个杂志是比较慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Dec 24 14:18:54 CST 2023, time=2023-12-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2190233, encodeId=e3cf21902338a, content=投稿通过初始审查后变为Peer review, "We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.",这是还没分配编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=020a5519115, createdName=火舞, createdTime=Thu Feb 29 23:01:19 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186670, encodeId=db5621866e06e, content=请问下大家，一审是大修，二审小修的话还会送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d2e5075184, createdName=1459fafam67暂无昵称, createdTime=Fri Feb 09 11:31:44 CST 2024, time=2024-02-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2162924, encodeId=d678216292445, content=我的天啊，这个杂志是没有人吗？怎么这么慢？已经半年了还在peer review，别再等几个月回来个拒绝，那我就可以泪洒长江了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88438132359, createdName=ms1000001361403109, createdTime=Sun Oct 15 20:23:22 CST 2023, time=2023-10-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1053746, encodeId=75fe1053e4663, content=审稿速度:2.0 经验分享：7.16投稿，9.20小修，要补动物实验，加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/f561376675e24537beed7d75b145e112/869c7ba506174d3d9b0c77a2ea6180b2.jpg, createdBy=4fe22307227, createdName=小啵啵嘟, createdTime=Wed Sep 22 11:57:09 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214367, encodeId=1099121436e25, content=偏重的研究方向：肿瘤;Cancer 经验分享：我的二审修回1个月了，都还是reviewers invited，有没有小伙伴能指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/acd275c8ee710a029c1f67cc80ff2472.jpg, createdBy=28492314309, createdName=章晓风, createdTime=Tue Apr 26 00:13:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198917, encodeId=5e2f119891e60, content=偏重的研究方向：肿瘤;细胞生物学 经验分享：2021-11-15投稿，2022-03-01接收，两个审稿人提出了十几条意见，认真回复了，让补实验没有补，后来修回以后审稿人没有意见了又找了第三个审稿人，让补实验没有补，小修回去接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu Mar 03 01:04:38 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2022-04-26 章晓风

偏重的研究方向：肿瘤;Cancer
经验分享：我的二审修回1个月了，都还是reviewers invited，有没有小伙伴能指点迷津

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197688, encodeId=3cb0219e688b1, content=这个杂志平均审稿时间感觉不是官网上说的那么快啊，我的1月底投，现在都还在外审，只有1个外审意见回来了，还在等另外一个外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5fc8852742, createdName=ms6000001772473137, createdTime=Wed Apr 10 01:37:05 CST 2024, time=2024-04-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2197377, encodeId=a25b219e37740, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：纯生信现在不要了得加实验主要审稿速度2023年后就出奇的慢，3个半月一审意见才回来而且只有一个审稿人的意见，修回后一直同行评审了20天了，啥动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67526580859, createdName=ms9000000438456105, createdTime=Mon Apr 08 12:01:16 CST 2024, time=2024-04-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2185531, encodeId=713d218553185, content=editor appointed半个多月了，要催么，最近大家有投稿的么，什么时候能进入下一个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db952300595, createdName=12206c44m25(暂无昵称), createdTime=Fri Feb 02 17:24:29 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176856, encodeId=74c821e685641, content=偏重的研究方向：肿瘤;生信 经验分享：投稿第二天就editor appointed了，现在已经差不多两个月了，发了邮件催，回复说已经在找审稿人了。这个杂志是比较慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Dec 24 14:18:54 CST 2023, time=2023-12-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2190233, encodeId=e3cf21902338a, content=投稿通过初始审查后变为Peer review, "We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.",这是还没分配编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=020a5519115, createdName=火舞, createdTime=Thu Feb 29 23:01:19 CST 2024, time=2024-02-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186670, encodeId=db5621866e06e, content=请问下大家，一审是大修，二审小修的话还会送外审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d2e5075184, createdName=1459fafam67暂无昵称, createdTime=Fri Feb 09 11:31:44 CST 2024, time=2024-02-09, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2162924, encodeId=d678216292445, content=我的天啊，这个杂志是没有人吗？怎么这么慢？已经半年了还在peer review，别再等几个月回来个拒绝，那我就可以泪洒长江了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88438132359, createdName=ms1000001361403109, createdTime=Sun Oct 15 20:23:22 CST 2023, time=2023-10-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1053746, encodeId=75fe1053e4663, content=审稿速度:2.0 经验分享：7.16投稿，9.20小修，要补动物实验，加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/f561376675e24537beed7d75b145e112/869c7ba506174d3d9b0c77a2ea6180b2.jpg, createdBy=4fe22307227, createdName=小啵啵嘟, createdTime=Wed Sep 22 11:57:09 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214367, encodeId=1099121436e25, content=偏重的研究方向：肿瘤;Cancer 经验分享：我的二审修回1个月了，都还是reviewers invited，有没有小伙伴能指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/31/acd275c8ee710a029c1f67cc80ff2472.jpg, createdBy=28492314309, createdName=章晓风, createdTime=Tue Apr 26 00:13:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198917, encodeId=5e2f119891e60, content=偏重的研究方向：肿瘤;细胞生物学 经验分享：2021-11-15投稿，2022-03-01接收，两个审稿人提出了十几条意见，认真回复了，让补实验没有补，后来修回以后审稿人没有意见了又找了第三个审稿人，让补实验没有补，小修回去接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu Mar 03 01:04:38 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2022-03-03 ms1000000289565013

偏重的研究方向：肿瘤;细胞生物学
经验分享：2021-11-15投稿，2022-03-01接收，两个审稿人提出了十几条意见，认真回复了，让补实验没有补，后来修回以后审稿人没有意见了又找了第三个审稿人，让补实验没有补，小修回去接收。

51 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务